EVT:ETR
Evotec SE
၂.၄၄ €
arrow_downward
-၀.၆၅%(-၀.၀၁၆) 1D
အောက် ၁၃, GMT+၂ ၁၇:၃၅:၀၄ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EVT...
Open
၂.၄၄ €
High
၂.၆၀ €
Low
၂.၄၁ €
Mkt. cap
၄၄.၀၄ ကုဋေ
Avg. vol.
၉.၇၁ သိန်း
Volume
၁.၆၂ သန်း
52-wk high
၇.၃၀ €
52-wk low
၂.၄၁ €
EPS
-၁.၁၁ €
Shares outstanding
၁၇.၇၉ ကုဋေ
No. of employees
၄ ထောင်
Open
၂.၄၄ €
High
၂.၆၀ €
Low
၂.၄၁ €
Mkt. cap
၄၄.၀၄ ကုဋေ
Avg. vol.
၉.၇၁ သိန်း
Volume
၁.၆၂ သန်း
52-wk high
၇.၃၀ €
52-wk low
၂.၄၁ €
EPS
-၁.၁၁ €
Shares outstanding
၁၇.၇၉ ကုဋေ
No. of employees
၄ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁၁ နာရီ
Evotec stock trades at EUR 2.51, 2.87 percent above its low
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁၄ နာရီ
Evotec announced research chief exit while Evotec stock gains 2.85 percent
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁ ရက်
Evotec stock gains 0.41 percent after-hours to EUR 2.47 versus EUR 2.46 Xetra close
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁ ရက်
Evotec stock trades at EUR 2.61 with EUR 0.5 billion market value
Profile
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more.
On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
About Evotec SE